ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Health Assessment Questionnaire"

  • Abstract Number: 1370 • 2019 ACR/ARP Annual Meeting

    Not All Joints Are Equal: Challenge DAS28 System and Identify Factors Leading to a Mismatch Between T2T and HAQ Among RA Patients Through Data Mining from Smart System of Disease Management (SSDM)

    Jing Yang1, Zhenbiao Wu 2, Yongfu Wang 3, Hua Wei 4, Yu Zhang 1, Xiaoling Liu 5, Xiaofeng Rong 6, Jinmei Zou 1, Xiaofei Shi 7, Hongbin Li 8, Rui Wu 9, Xiaoli Deng 10, Huiqiong Zhou 11, Yuan Jia 12, Wei Zhao 13, Shi Chen 12, Xuewu Zhang 12, Yingnan Li 14, Yingkun Nie 14, Yifang Mei 15, Jianyu Zhang 16, Hanyou Mo 17, li Sun 18, Yanfei Chen 19, Haili Shen 20, Dongsheng Li 21, Yonggang Zhao 22, Hui Xiao 23, Bing Wu 24, Yuhua Jia 22 and Fei Xiao 25, 1Central Hospital of MianYang, Mianyang, Sichuan, China (People's Republic), 2The First Affiliated Hospital of The Fourth Military Medical University, Xian, Shanxi, China (People's Republic), 3The First Affiliated Hospital of BaoTou Medical College, Baotou, Nei Mongol, China (People's Republic), 4Northern Jiangsu People's Hospital, Yangzhou, China (People's Republic), 5The 1st Affiliated Hospital of Guangzhou University of TCM, Guangzhou, China (People's Republic), 6The 1st Affiliated hospital of Chongqing medical University, Chongqing, Chongqing, China (People's Republic), 7First Affiliated Hospital of Henan University of Science and Technology, luoyang, Henan, China (People's Republic), 8The Affiliated Hospital of Inner Mongolia Medical University, Huhhot, Nei Mongol, China (People's Republic), 9The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China (People's Republic), 10Peking University Third Hospital, Beijing, Beijing, China (People's Republic), 11Fourth Medical Center of PLA Genal Hospital, Beijing, Beijing, China (People's Republic), 12Peking University People's Hospital, Beijing, Beijing, China (People's Republic), 13Chinese PLA General Hospital, Beijing, Beijing, China (People's Republic), 14The 2nd Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China (People's Republic), 15The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China (People's Republic), 16The Third Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong, China (People's Republic), 17Affiliated Hospital of Guilin Medical University, Guilin, Guangxi, China (People's Republic), 18The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China (People's Republic), 19The First Hospital of Lanzhou University, Lanzhou, Gansu, China (People's Republic), 20The Second Hospital of Lanzhou University, Lanzhou, Gansu, China (People's Republic), 21Ganzhou People's Hospital, Ganzhou, Jiangxi, China (People's Republic), 22Shanghai Gothic Internet Technology Co., Ltd., Shanghai, Shanghai, China (People's Republic), 23Shanghai Gothic Internet Technology Co., Ltd, shanghai, Shanghai, China (People's Republic), 24Shanghai Gothic Internet Technology Co., Ltd, Shanghai, China (People's Republic), 25Shanghai Gothic Internet Technology Co., Ltd., shanghai, China (People's Republic)

    Background/Purpose: Treat to target (T2T), achieving a DAS28 score lower than 3.2, is the strategy recommended by ACR and EULAR. Health assessment questionnaire (HAQ) is…
  • Abstract Number: 1600 • 2018 ACR/ARHP Annual Meeting

    Psychometric Properties of the Assessment of Spa International Society Health Index in Patients with Active As/Radiographic Axial Spa in a Phase 3 Clinical Study

    Uta Kiltz1, Désirée van der Heijde2, Annelies Boonen3,4, Lianne S. Gensler5, Theresa Hunter6, Yan Dong6, Kathleen Wyrwich6, Hilde Carlier6 and Jürgen Braun1,7, 1Rheumazentrum Ruhrgebiet, Herne, Germany, 2Leiden University Medical Centre, Leiden, Netherlands, 3Department of Internal Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 4Caphri Research Institute, Maastricht, Netherlands, 5University of California San Francisco, San Francisco, CA, 6Eli Lilly and Company, Indianapolis, IN, 7Ruhr Universität Bochum, Bochum, Germany

    Background/Purpose: The Assessment of SpA international Society Health Index (ASAS HI) was developed to assess function, disability, and health in patients (pts) with SpA. This…
  • Abstract Number: 1865 • 2018 ACR/ARHP Annual Meeting

    Ixekizumab Significantly Improves Self-Reported Overall Functioning and Health in Patients with Active As/Radiographic Axial Spa Naive to Biologic DMARD Therapy: 16‑Week Results of a Phase 3 Randomized, Active and Placebo-Controlled Trial

    Uta Kiltz1, Désirée van der Heijde2, Annelies Boonen3,4, Lianne S. Gensler5, Theresa Hunter6, Fangyi Zhao6, Hilde Carlier6 and Jürgen Braun1,7, 1Rheumazentrum Ruhrgebiet, Herne, Germany, 2Leiden University Medical Centre, Leiden, Netherlands, 3Department of Medicine, Division of Rheumatology, Maastricht University Medical Center, Maastricht, Netherlands, 4Caphri Research Institute, Maastricht, Netherlands, 5School of Medicine, UCSF, San Francisco, CA, 6Eli Lilly and Company, Indianapolis, IN, 7Ruhr Universität Bochum, Bochum, Germany

    Background/Purpose: The Assessment of SpA international Society Health Index (ASAS HI) is a relatively new measure to assess function, disability, and health in patients with…
  • Abstract Number: 1923 • 2018 ACR/ARHP Annual Meeting

    Treating Rheumatoid Arthritis to Target: Is Low Disease Activity Good Enough?

    Elena Nikiphorou1, Sam Norton2, Adam Young3, Lewis Carpenter2, Josh Dixey4, David Walsh5 and Patrick Kiely6, 1Academic Rheumatology, Department of Inflammation Biology, King's College London, London, Great Britain, 2Academic Rheumatology, King's College London, London, United Kingdom, 3University of Hertfordshire, Hertford, United Kingdom, 4Rheumatology, The Royal Wolverhampton, Wolverhampton, United Kingdom, 5Academic Rheumatology, University of Nottingham, Nottingham, Great Britain, 6Rheumatology Dept, St Georges Hospital, London, Great Britain

    Treating Rheumatoid Arthritis To Target: Is Low Disease Activity Good Enough? Background/Purpose:  It is now widely recognised that treat-to-target (T2T) principles in rheumatoid arthritis (RA)…
  • Abstract Number: 2491 • 2018 ACR/ARHP Annual Meeting

    Treat-to-Target (T2T) Is Not Enough: Identify Factors Leading to a Mismatch between T2T and HAQ Among RA Patients through Data Mining from Smart System of Disease Management (SSDM)

    Jing Yang1, Hua Wei2, Jianlin Huang3, Wenqiang Fan4, Hongzhi Wang5, Yongfu Wang6, Rong Mu7, Chun Li8, Jinmei Zou1, Yu Zhang1, Bin Wu9, Jianling Dong1, Xiaofei Shi10, Xinwang Duan11, Jianhong Wu12, Fang He13, Hong Liu1, Zhijun Li14, Guosheng Wang15, Shengguang Li16, Bei Wang17, Yanjie Hao18, Huiqiong Zhou19, Haili shen20, Yang Cui21, Wenhui Huang22, Qing-chun Huang23, Hui Xiao24, Yuhua Jia24, Fei Xiao24 and Feng-Chun Zhang25, 1Department of rheumatology, Central Hospital of MianYang, Sichuan, Mian Yang, China, 2Northern Jiangsu People's Hospital, Yangzhou, China, 3Department of rheumatology, The Sixth Hospital Affiliated to Sun yat-sen University, Guangzhou, China, 4Department of rheumatology, Central Hospital of XinXiang, Henan, XinXiang, China, 5The First Hospital of Jiaxing, Jiaxing, China, 6The First Affiliated Hospital of BaoTou Medical College, Baotou, China, 7Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China, 8Peking University People's Hospital, Beijing, China, 9Department of Rheumatology, Chongqing Hospital of Traditional Chinese Medicine, Chongqing, China, 10The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China, 11Department of rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, China, 12Dazhou Central Hospital, Dazhou, China, 13Central Hospital of Sui Ning, Sichuan, Suining, China, 14The First Affiliated Hospital of Bengbu Medical College, Bengbu, China, 15Department of rheumatology, Anhui Medical University Affiliated Provincial Hospital, Hefei, China, 16Peking University International Hospital, Beijing, China, 17Beijing Hospital of Traditional Chinese Medicine (TCM), Beijing, China, 18The First Affiliated Hospital of Beijing University, Beijing, China, 19The First Affiliated Hospital of PLA General Hospital, Beijing, China, 20Department of Rheumatology and Immunology, Second Hospital of Lanzhou University, lanzhou, China, 21Guangdong General Hospital, Guangzhou, China, 22The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China, 23Rheumatology, Guangzhou Provincial Hospital of Traditional Chinese Medicine, Guangzhou, China, 24Shanghai Gothic Internet Technology Co., Ltd., Shanghai, China, 25Peking Union Medical College Hospital, Beijing, China

    Background/Purpose: T2T, achieving a DAS28 score lower than 3.2 is the main management strategy recommended by ACR and EULAR. HAQ is the most widely used…
  • Abstract Number: 2492 • 2018 ACR/ARHP Annual Meeting

    Pattern Shift and Influential Factors in Promoting Treat-to-Target (T2T) for Follow-up RA Patients with a Rheumatologist-Patient Interactive Smart System of Disease Management (SSDM): A Cohort Study from China

    Rong Mu1, Chun Li2, Jing Yang3, Hua Wei4, Jianlin Huang5, Wenqiang Fan6, Yongfu Wang7, Hongzhi Wang8, Jinmei Zou3, Xiaofei Shi9, Xiafei Xin10, Jianhong Wu11, Fen Li12, Shouxin Li13, Huiqin Yang14, Anbing Zhang15, Dongbao Zhao16, Jinchang He17, Junli Zhang18, Luo Li19, Peng Ji20, Xiaofeng Rong21, Feng Jiang22, Ling Wang23, Yuhua Jia24, Fei Xiao24 and Zhan-Guo Li25, 1Department of Rheumatology and Immunology, Peking University People's Hospital, Beijing, China, 2Peking University People's Hospital, Beijing, China, 3Department of rheumatology, Central Hospital of MianYang, Sichuan, Mian Yang, China, 4Northern Jiangsu People's Hospital, Yangzhou, China, 5Department of rheumatology, The Sixth Hospital Affiliated to Sun yat-sen University, Guangzhou, China, 6Department of rheumatology, Central Hospital of XinXiang, Henan, XinXiang, China, 7The First Affiliated Hospital of BaoTou Medical College, Baotou, China, 8The First Hospital of Jiaxing, Jiaxing, China, 9The First Affiliated Hospital of Henan University of Science and Technology, Luoyang, China, 10Ningbo First Hospital, Zhejiang, Ningbo, China, 11Dazhou Central Hospital, Dazhou, China, 12The Second Xiangya Hospital of Central South University, Changsha, China, 13Tongji Hospital,Tongji Medical College,Huazhong University of Science and Technology, wuhan, China, 14Wuhan No 1 Hospital, wuhan, China, 15Xiangyang Central Hospital, Xiangyang, China, 16Changhai Hospital of Shanghai, Shanghai, China, 17PanZhiHua Central Hospital, Panzhihua, China, 18Xi 'an no.5 hospital, Xian, China, 19The First Affiliated Hospital of XinJiang Medical University, Wulumuqi, China, 20[email protected], Wulumuqi, China, 21Affiliated hospital of Chongqing medical University, Chongqing, China, 22Huzhou Third People's Hospital, Huzhou, China, 23Zao Zhuang Municipal Hospital, zaozhuang, China, 24Shanghai Gothic Internet Technology Co., Ltd., Shanghai, China, 25Rheum/Immunology, Peking University People's Hospital, Beijing, China

    Background/Purpose: Treat-to-Target (T2T), achieving a DAS28 score lower than 2.6 (remission, Rem) or below 3.2 (low disease activity, LDA), is the main management strategy recommended…
  • Abstract Number: 2687 • 2018 ACR/ARHP Annual Meeting

    Patient-Level Evaluation of Components of the American College of Rheumatology Combined Response Index in Systemic Sclerosis (CRISS) Using Patient-Reported Anchors

    Vivek Nagaraja1, John Powers2, Celia J. F. Lin3, Benjamin Brennan4, Veronica J. Berrocal5 and Dinesh Khanna1, 1Division of Rheumatology, Department of Internal Medicine, University of Michigan Scleroderma Program, University of Michigan, Ann Arbor, MI, 2University of Maryland School of Medicine, Rockville, MD, 3Genentech, Inc., South San Francisco, CA, 4School of Public Health, University of Michigan, Ann Arbor, MI, 5Div of Rheumatology, University of Michigan, Ann Arbor, MI

    Background/Purpose: Treatment benefit is demonstrated by evidence that interventions have positive impacts on how patients feel, function, and/or survive (FDA Guidance, 21CFR314.510). The ACR CRISS,…
  • Abstract Number: 223 • 2018 ACR/ARHP Annual Meeting

    The Effect of Concomitant Diabetes on RA-Related Outcomes: Results from the Acr’s RISE Registry

    Huifeng Yun1, Fenglong Xie1, Lang Chen1, Shuo Yang1, Leticia Ferri2, Evo Alemao2, Tammy Curtice2 and Jeffrey R. Curtis1, 1University of Alabama at Birmingham, Birmingham, AL, 2Bristol-Myers Squibb, Princeton, NJ

    Background/Purpose: The impact of concomitant comorbidities on RA outcomes is of high interest, and some evidence suggests that patients (pts) with RA and diabetes may…
  • Abstract Number: 332 • 2018 ACR/ARHP Annual Meeting

    Components of Impaired Physical Function and Disability in a Non-Rheumatic Population. Normative Values of the Health Assessment Questionnaire Disability Index

    C Alejandro Arce-Salinas1, H FABRICIO ESPINOSA-ORTEGA2 and Olivia Enriquez-Antonio3, 1INTERNAL MEDICINE, Hospital Central Sur PEMEX, MEXICO, Mexico, 2Rheumatology Department, Karolinska Universitetssjukhuset, Stockolm, Sweden, 3Internal Medicine, Hospital Central Sur PEMEX, mexico, Mexico

    Background/Purpose: HAQ-Di is broadly used to measure disability in RA, its assessment might influence taking decision process. However, it cannot differentiate disability related to arthritis,…
  • Abstract Number: 335 • 2018 ACR/ARHP Annual Meeting

    Cross-Cultural Validity of Functional Status Assessment Measures for Rheumatoid Arthritis

    Stephanie Kulhawy-Wibe1, JoAnn Zell2,3, Kaleb Michaud4, Jinoos Yazdany5, Linda S. Ehrlich-Jones6,7, Carter Thorne8, Donna Everix9 and Claire Barber10, 1University of Calgary, Calgary, AB, Canada, 2Denver Health, Denver, CO, 3University of Colorado, Denver, CO, 4Rheumatology, University of Nebraska Medical Center, Omaha, NE, 5University of California, San Francisco, San Francisco, CA, 6Shirley Ryan AbilityLab, Chicago, IL, 7Northwestern University Feinberg School of Medicine, Chicago, IL, 8University of Toronto, Newmarket, ON, Canada, 9OnMyCare Home Health, Fremont, CA, 10Medicine, Cumming School of Medicine, University of Calgary, Calgary, AB, Canada

    Background/Purpose: Functional Status Assessment Measures (FSAMs) are important outcome measures in Rheumatoid Arthritis (RA) as poor function is a predictor for mortality and associated with…
  • Abstract Number: 1434 • 2018 ACR/ARHP Annual Meeting

    Patient-Proxy Agreement on Health-Related Quality of Life in Juvenile Fibromyalgia Syndrome

    Sabrina Gmuca, Audrey Urquhart and David D. Sherry, Pediatric Rheumatology, Children's Hospital of Philadelphia, Philadelphia, PA

    Background/Purpose: The administration of proxy-reported health-related quality of life (HRQoL) measures in the assessment of juvenile fibromyalgia syndrome (JFMS) is common but its added clinical…
  • Abstract Number: 1533 • 2018 ACR/ARHP Annual Meeting

    Simulating Population Disability Outcomes for Alternative Treatment Pathways in Patients with Active Rheumatoid Arthritis

    Josephine Mauskopf1, Mahdi Gharaibeh2, David Wamble1, David H. Collier2, Bradley S. Stolshek2 and Eric L. Matteson3, 1RTI Health Solutions, Research Triangle Park, NC, 2Amgen Inc., Thousand Oaks, CA, 3Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN

    Background/Purpose:  Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disorder that causes joint pain and swelling, bone erosions, and deformity.  This debilitating disease can severely…
  • Abstract Number: 342 • 2017 ACR/ARHP Annual Meeting

    Health Related Quality of Life Is Comparable in Psoriatic Arthritis and Rheumatoid Arthritis Patients in Spite of Different Disease Activity. SF-36 Data from a Large Prospective Observational Multicentre Study

    Brigitte Michelsen1,2, Till Uhlig1, Eirik K Kristianslund1, Joseph Sexton1, Elisabeth Lie1, Karen M Fagerli3, Hilde B Hammer4, Glenn Haugeberg5,6 and Tore K Kvien7, 1Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Dept. of Rheumatology, Hospital of Southern Norway Trust, Kristiansand, Norway, 3Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 4Dept of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 5Martina Hansens Hospital, Bærum, Norway, 6NTNU, Norwegian University of Science and Technology, Trondheim, Norway, 7Diakonhjemmet Hospital, Oslo, Norway

    Background/Purpose: It is well established that RA patients have lower health related quality of life (HRQoL) across several domains compared with the general population, whereas…
  • Abstract Number: 928 • 2017 ACR/ARHP Annual Meeting

    Online Consultation for Chinese Patients with Rheumatic Diseases Based on Smart System of Disease Management (SSDM) Mobile Tool: A Study of Medical Economics

    Fei Xiao1, Rui Wu2, Zhenchun Zhang3, Weiqi Min4, Yanchun Tang5, Xinwang Duan6, Lingfei Mo7, Zhaojun Guo8, Yanping Zhao9, Henglian Wu10, Xia Xu11, Feng Jiang12, Jing Yu13, Jianhong Qiang14, Yan Wang9, Ruijie Wu15, Anbing Zhang16, Limei Gu17, Hui Xiao1, Yuhua Jia1, Yuan Liu1, Bing Wu1, Chunhui Shi1 and Fengchun Zhang18, 1Gothic Internet Technology Corporation, Shanghai, China, 2The First Affiliated Hospital of Nanchang University, Nanchang, China, 3People's Hospital of Linyi, Shandong, Linyi, China, 4Heze Municiple Hospital, Heze, China, 5Yantai YuHuangDing Hospital, Yantai, China, 6Department of rheumatology, The Second Affiliated Hospital of Nanchang University, Nanchang, China, 7The First Affiliated Hospital of Xi'an Jiao Tong University, Xi'an, China, 8The First People's Hospital of Huainan City, Huainan, China, 9First Affiliated Hospital of Harbin Medical University, Harbin, China, 10Dongguan Donghua Hospital, Dongguan, China, 11Changhai Hospital, Shanghai, China, 12Huzhou Third People's Hospital, Huzhou, China, 13The First Hospital Affiliated with the University of Traditional Chinese Medicine in Liaoning Province, Shenyang, China, 14Yan'an People's Hospital, Yan'an, China, 15The Second Affiliated Hospital of Shanxi Medical College, Taiyuan, China, 16Xiangyang Central Hospital, Xiangyang, China, 17Central People's Hospital of Siping, Siping, China, 18Peking Union Medical College Hospital, Beijing, China

    Background/Purpose: China doesn’t have efficient primary medical care and referral system. Patients can choose any hospitals or any doctors they like to seek medical care.…
  • Abstract Number: 1360 • 2017 ACR/ARHP Annual Meeting

    Validation of the Health Assessment Questionnaire-Upper Extremity (HAQUP) in Patients with Rheumatoid Arthritis

    Juan Manuel Bande1, José Ángel Caracciolo1, Silvia Beatriz Papasidero1, María Julia Santa Cruz2, María Alejandra Medina1, Diana Klajn3, María Gabriela Battaglia4, Julieta Giantinoto4 and Florencia Pelagagge4, 1Rheumatology Department, Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires, Argentina, 2Section of Rheumatology, Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires, Argentina, 3Research Committee, Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires, Argentina, 4Occupational Therapy Department, Hospital General de Agudos Dr. Enrique Tornú, Buenos Aires, Argentina

    Background/Purpose: HAQ is considered the gold standard for the evaluation of functional capacity in patients with RA, even though it doesn´t focus in any particular…
  • 1
  • 2
  • 3
  • …
  • 7
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology